This page provides Regulatory news filings submitted by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.

Hamilton, Bermuda:  10th, November 2022 – In a filing with the Bermuda Stock Exchange (“BSX”), Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results Raises Total Revenue

Guidance Mid-point. The full filing stated:

 

Third Quarter 2022 Financial Results

 

# # # #

 

About the BSX

The Bermuda Stock Exchange (the BSX) is the global leading exchange for the listing of insurance linked securities (ILS) and specialises in listing services for ILS, debt, funds, derivative warrants, equities and structured securities. With over 1,300 securities listed, the BSX is uniquely positioned between Europe and the Americas to deliver speed to market for international issuers. Part of the MIAX Exchange Group, the BSX facilitates electronic trading and settlement and operates the Bermuda Securities Depositary platform.  Established in 1971, the BSX is a member of the World Federation of Exchanges, an associate member of IOSCO, holds Designated Offshore Securities Market (DOSM) status from the US SEC and is a recognised exchange in the UK, Ireland, Canada and Australia for tax purposes. To learn more about the BSX visit https://www.bsx.comand or contact info@bsx.com